Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:51:54 +0200Wed, 17 Apr 2024 16:03:00 +0200Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 50, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xolairHuman medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 50, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xolairWed, 17 Apr 2024 16:03:00 +0200Human medicineXolair : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-606_en_0.pdfXolair : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-606_en_0.pdfThu, 21 Dec 2023 10:29:00 +0100Human medicine